---
title: "Science Group Tightens Share Structure With Targeted Buyback"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/276422981.md"
description: "Science Group plc has repurchased 17,500 of its ordinary shares at an average price of 547 pence, representing about 0.04% of prior voting rights. This buyback reduces the free float and increases treasury holdings, indicating a strategic move to enhance shareholder value. The company now has 42,819,312 ordinary shares in issue, excluding treasury stock. Analysts rate the stock as a Buy with a price target of £621.00, citing strong financial performance and share buybacks as key factors, although short-term technical indicators suggest caution."
datetime: "2026-02-20T08:04:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276422981.md)
  - [en](https://longbridge.com/en/news/276422981.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276422981.md)
generator: "portal-rs"
---

# Science Group Tightens Share Structure With Targeted Buyback

### President's Day Sale - 70% Off

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Science ( (GB:SAG) ) just unveiled an announcement.

Science Group plc has repurchased 17,500 of its 1 pence ordinary shares at an average price of 547 pence, with all shares bought at the same price through Panmure Liberum Limited. The transaction represents around 0.04% of prior voting rights, and the shares will be held in treasury, leaving 42,819,312 ordinary shares in issue excluding treasury stock and 3,366,562 shares held in treasury, a figure shareholders can use to assess disclosure thresholds under FCA rules.

The buyback slightly reduces the free float while increasing treasury holdings, signaling continued use of capital management tools to influence share structure and potentially enhance shareholder value. By clarifying the updated share count for regulatory calculations, the company also supports transparency for investors monitoring their notifiable interests and compliance with disclosure requirements.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

**Spark’s Take on GB:SAG Stock**

According to Spark, TipRanks’ AI Analyst, GB:SAG is a Outperform.

Science Group’s strong financial performance and strategic corporate actions, such as share buybacks, are the most significant factors contributing to its score. The stock’s undervaluation and solid dividend yield further enhance its attractiveness. However, technical indicators suggest caution in the short term.

To see Spark’s full report on GB:SAG stock, click here. 

**More about Science**

Science Group plc is a UK-based company listed on AIM under the ticker SAG, operating a diversified portfolio of science, engineering and technology businesses. The group provides consultancy, product development and related technical services to industrial and commercial clients across multiple markets, with an active capital management approach including share buybacks.

**Average Trading Volume:** 51,019

**Technical Sentiment Signal:** Strong Buy

**Current Market Cap:** £233.5M

### Related Stocks

- [SAG.UK](https://longbridge.com/en/quote/SAG.UK.md)

## Related News & Research

- [Positive Report for Admiral (ADM) from Morgan Stanley](https://longbridge.com/en/news/298178420.md)
- [Spain's Ignis targets October IPO to raise up to €600 million, report says](https://longbridge.com/en/news/298175633.md)
- [Baidu’s Xiaodu schedules AI hardware launch for Sept. 8](https://longbridge.com/en/news/298171383.md)
- [Goldman Sachs Sticks to Its Buy Rating for Tritax Big Box REIT (BBOX)](https://longbridge.com/en/news/298182619.md)
- [Essity Advances SEK 3bn Share Buyback, Boosts Treasury Holdings](https://longbridge.com/en/news/298184582.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**